**Core Concept**
The primary target for diphenoxylate is the mu-opioid receptors in the intestinal tract, which are responsible for slowing intestinal motility and reducing the frequency of bowel movements.

**Why the Correct Answer is Right**
Diphenoxylate acts as an opioid agonist, specifically binding to mu-opioid receptors in the intestinal tract. This binding causes a decrease in the contraction of intestinal smooth muscle, leading to a reduction in the frequency of bowel movements and alleviating symptoms of diarrhea. The mu-opioid receptors are a subtype of opioid receptors that are primarily responsible for the analgesic and motor effects of opioids.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because diphenoxylate does not primarily target the kappa-opioid receptors, which are involved in analgesia and dysphoria. While kappa-opioid receptors are also present in the intestinal tract, they are not the primary target of diphenoxylate.
**Option B:** This option is incorrect because diphenoxylate does not primarily target the delta-opioid receptors, which are involved in analgesia and mood regulation. While delta-opioid receptors are present in the intestinal tract, they are not the primary target of diphenoxylate.
**Option C:** This option is incorrect because diphenoxylate does not primarily target the serotonin receptors, which are involved in regulating intestinal motility. While serotonin receptors are present in the intestinal tract, they are not the primary target of diphenoxylate.
**Option D:** This option is incorrect because diphenoxylate does not primarily target the acetylcholine receptors, which are involved in regulating intestinal smooth muscle contraction. While acetylcholine receptors are present in the intestinal tract, they are not the primary target of diphenoxylate.

**Clinical Pearl / High-Yield Fact**
Diphenoxylate is often used in combination with atropine to prevent abuse due to its potential for dependence. The atropine serves as a deterrent, as it causes anticholinergic side effects that are unpleasant but not typically life-threatening.

**Correct Answer:** C. mu-opioid receptors